Skip to main content
SpringerLink
Log in
Book cover

Key Statistical Concepts in Clinical Trials for Pharma

  • Book
  • © 2012

Overview

Authors:
  1. J. Rick Turner

    1. Cardiac Safety Services, Quintiles, Durham, USA

    View author publications

    You can also search for this author in PubMed   Google Scholar

  • Discusses key statistical concepts
  • Includes supplementary material: sn.pub/extras

Part of the book series: SpringerBriefs in Pharmaceutical Science & Drug Development (BRIEFSPSDD)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (6 chapters)

  1. Front Matter

    Pages i-ix
    Download chapter PDF

  2. Setting the Scene

    • J. Rick Turner
    Pages 1-10

  3. Analyzing Safety Data

    • J. Rick Turner
    Pages 11-21

  4. Assessing Efficacy Data

    • J. Rick Turner
    Pages 23-32

  5. Confidence Intervals: Additional Commentary

    • J. Rick Turner
    Pages 33-40

  6. Meta-Methodology

    • J. Rick Turner
    Pages 41-49

  7. Benefit–Risk Estimation

    • J. Rick Turner
    Pages 51-58

  8. Back Matter

    Pages 59-61
    Download chapter PDF
Back to top

Keywords

About this book

This Brief discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market). These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance.

Authors and Affiliations

  • Cardiac Safety Services, Quintiles, Durham, USA

    J. Rick Turner

About the author

J. Rick Turner, PhD, is an experimental research scientist and clinical trialist, and currently Senior Scientific Director, Integrated Cardiovascular Safety, Quintiles. With his colleagues, he provides Sponsors with consultation, strategic and regulatory insights, and operational support during cardiac safety assessments throughout clinical development programs.  He is particularly interested in the development of drugs for Type 2 Diabetes Mellitus and obesity.Dr Turner is also a Senior Fellow at the Center for Medicine in the Public Interest (New York) and Editor-in-Chief of the DIA’s peer-reviewed Drug Information Journal.  He has published 12 previous books, 65 peer-reviewed papers, and many articles in professional journals. His books include:

·         Turner JR, 2011, A Concise Guide to Clinical Trials. Chapel Hill, NC: Turner Medical Communications LLC.

·         Turner JR, 2010, New Drug Development: An Introduction to Clinical Trials, 2nd Edition.  New York: Springer.

·         Turner JR, Durham TA, 2009, Integrated Cardiac Safety: Assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance. Hoboken, NJ: John Wiley & Sons.

·         Durham TA, Turner JR, 2008, Introduction to Statistics in Pharmaceutical Clinical Trials.  London: Pharmaceutical Press.

Dr Turner is also a Senior Fellow at the Center for Medicine in the Public Interest (New York) and Editor-in-Chief of the DIA’s peer-reviewed Drug Information Journal.  He has published 12 previous books, 65 peer-reviewed papers, and many articles in professional journals. His books include:

·         Turner JR, 2011, A Concise Guide to Clinical Trials. Chapel Hill, NC: Turner Medical Communications LLC.

·         Turner JR, 2010, New Drug Development: An Introduction to ClinicalTrials, 2nd Edition.  New York: Springer.

·         Turner JR, Durham TA, 2009, Integrated Cardiac Safety: Assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance. Hoboken, NJ: John Wiley & Sons.

·         Durham TA, Turner JR, 2008, Introduction to Statistics in Pharmaceutical Clinical Trials.  London: Pharmaceutical Press.

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation